Clinical utility of novel diabetes subgroups in predicting vascular complications and mortality: up to 25 years of follow-up of the HUNT study
Bjarkø VV, Haug EB, Langhammer A, et al.
BMJ Open Diabetes Res Care. 2024;12(6):e004493.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050
Ng M, Dai X, Cogen RM et al. GBD 2021 US Obesity Forecasting Collaborators
Lancet. 2024:S0140-6736(24)01548-4.
Leggi
SGLT2 inhibitors, cardiovascular outcomes, and mortality across the spectrum of kidney disease: A systematic review and meta-analysis
Spiazzi BF, Piccoli GF, Wayerbacher LF, et al.
Diabetes Res Clin Pract. 2024:111933.
Leggi
Time to development of macrovascular complications and its predictors among type 2 diabetes mellitus patients at Jimma University Medical Center
Adare AF, Tiyare FT, Marine BT
BMC Endocr Disord. 2024;24(1):252.
Leggi
Hypoglycemic events may trigger acute ischemic stroke within 30 days in those with diabetes: a case-crossover study
Makam S, Stein LK, Dhamoon MS
Stroke. Pub. online 22 Nov 2024.
Leggi
Intensive blood-pressure control in patients with type 2 diabetes
Bi Y, Li M, Liu Y, et al.
N Engl J Med. Pub. online 16 Nov 2024.
Leggi
Effects of tirzepatide on the clinical trajectory of patients with heart failure, a preserved ejection fraction, and obesity
Zile MR, Borlaug BA, Kramer CM, et al.
Circulation. Pub. online 18 Nov 2024.
Leggi
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
Ostrominski JW, Højbjerg Lassen MC, Claggett BL, et al.
Eur Heart J. 2024:ehae780.
Leggi
Results from a randomized trial of intensive glucose management using CGM versus usual care in hospitalized adults with type 2 diabetes: the TIGHT study
Hirsch IB, Draznin B, Buse JB, et al.
Diabetes Care. 2024:dc241779.
Leggi
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
Galderisi A, Sims EK, Evans-Molina C, et al.
Diabetologia. Pub. online 19 Nov 2024.
Leggi